Combination Therapy, Drug Interactions, and Survival Outcomes in Metastatic Breast Cancer: A Pooled Analysis of Phase II Trials.
Background: The relationship between regimen complexity, treatment sequencing, and survival outcomes in metastatic breast cancer (MBC) remains poorly characterized. Objectives: To quantify how treatment complexity, line of therapy, and baseline performance status (PS) differentially affect progressi...
| Publicado en: | Clinical Medicine Insights: Oncology Vol. 20; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
7/25/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |